Coby is clear about its scope, and there is something to be said for that. It is a streamlined asynchronous service at $199 a month that handles weight and does not claim to handle anything else. Nobody is being misled here.
But this site measures providers against a single question — will you be seen whole — and Coby answers it in the negative by design. There is no place in the visit for a history of pain, no hormonal context, and no route by which your endometriosis reaches the person managing your care.
Here is how Coby Health reads against each promise of the Whole-Woman Charter. Each promise is marked none, partial or strong; price is shown but is never part of the rating. GLP-1 medications are not a treatment for endometriosis.
Everything runs by message, the pharmacy is not disclosed publicly, and the intake is built around weight alone. That produces zeroes on the first three Charter rows — not a criticism of how Coby performs, but a description of what it offers. Dose fit, human help and cost all sit at partial, describing a service that works reliably inside a deliberately narrow boundary.
The practical consequence is that you carry the context yourself. If your pain worsens, or a symptom seems connected to something other than the medication, there is no clinician holding your wider history to raise it with. For some people that is genuinely fine, particularly if a gynaecologist is already managing the endometriosis side. For others it recreates exactly the fragmentation that made getting diagnosed take years.
Put these to Coby Health in writing, and keep the reply.
Coby sits at the bottom of the Charter because the Charter asks for whole-person care and Coby offers a medication channel. It does that job without pretence. Judged as a way to be seen properly, almost everything this site asks for is outside what it sets out to do.
What is above comes from what this provider chooses to publish, and providers revise their terms without saying so — treat it as a starting point and check it yourself. Havelle is editorial, not clinical: none of this is medical advice, and GLP-1 medications are not a treatment for endometriosis.